Heparin Injection

Maa: Australia

Kieli: englanti

Lähde: Department of Health (Therapeutic Goods Administration)

Osta se nyt

Pakkausseloste Pakkausseloste (PIL)
24-05-2024
Valmisteyhteenveto Valmisteyhteenveto (SPC)
24-05-2024

Aktiivinen ainesosa:

Heparin sodium

Pakkausseloste

                                HEPARIN INJECTION
 
CONSUMER MEDICINE INFORMATION
   
 
 
WHAT IS IN THIS LEAFLET
This leaflet answers some common
questions about Heparin Injection. It
does not contain all the available
information. It does not take the
place of talking to your doctor or
pharmacist.
All medicines have benefits and
risks. Your doctor has weighed the
risks of you using Heparin Injection
against the benefits this medicine is
expected to have for you.
This medicine is likely to be used
while you are at the clinic or in
hospital. If possible, please read this
leaflet carefully before this medicine
is given to you. In some cases this
leaflet may be given to you after the
medicine has been used.
IF YOU HAVE ANY CONCERNS ABOUT
USING THIS MEDICINE, ASK YOUR
DOCTOR OR PHARMACIST.
KEEP THIS LEAFLET.
You may need to read it again.
WHAT HEPARIN
INJECTION IS USED FOR
Heparin Injection belongs to a group
of medicines known as
anticoagulants. Anticoagulants work
by decreasing the clotting ability of
your blood and help stop clots
forming in the blood vessels.
Anticoagulants are sometimes called
"blood thinners", although they do
not actually thin the blood. Heparin
will not dissolve blood clots that
have already formed, but it may
prevent any clots that have already
formed from becoming larger and
causing serious problems.
Heparin Injection is used for
prevention and treatment of diseases
caused by blood clots such as in
certain blood vessel, heart and lung
conditions. It is also used to prevent
blood clots from forming during
surgery, dialysis or blood
transfusions.
Heparin Injection may be used for
the treatment of other conditions that
are not mentioned above. Your
doctor will be able to tell you about
the specific condition for which you
have been prescribed Heparin
Injection.
This medicine is available only with
a doctor's prescription.
BEFORE YOU ARE GIVEN
HEPARIN INJECTION
_WHEN YOU MUST NOT BE GIVEN_
_IT_
DO NOT USE HEPARIN INJECTION IF
YOU:
•
have an allergy to heparin or pork
products
•
have, or may have, a bleeding
disease
                                
                                Lue koko asiakirja
                                
                            

Valmisteyhteenveto

                                Version: pfphepai11012 
Supersedes: pfphepai10611 
 
Page 1 of 13 
 
 
PRODUCT INFORMATION 
 
HEPARIN INJECTION 
HEPARIN SODIUM INJECTION (PORCINE MUCOUS) 
NAME OF THE MEDICINE 
Heparin sodium BP 
Heparin  is  a  heterogeneous  group  of  straight-chain  anionic  mucopolysaccharides,  called 
glycosaminoglycans,  possessing  anticoagulant  properties.  It  is  composed  of  polymers  of 
alternating  derivations  of  α-D-glucosamido  (_N_-sulfated  _O_-sulfated  or  _N_-acetylated)  and  _O_-
sulfated uronic acid (α-L-iduronic acid or β-D-glucuronic acid). 
HEPARIN CAS REGISTRY NUMBER IS 9005-49-6. 
DESCRIPTION
 
Heparin sodium is a preparation containing the sodium salt of a sulphated
glucosaminoglycan 
present in mammalian tissues.  It is prepared from the lungs or from the intestinal mucosae of 
pigs.    Heparin  sodium  is  a  white  or  almost  white  powder,  moderately  hygroscopic,  freely 
soluble in water. 
Heparin  Injection  is  a  clear,  colourless  to  straw  coloured,  sterile,  preservative-free  solution 
containing Heparin Sodium BP (porcine mucous) in Water for
Injections BP. 
PHARMACOLOGY 
CLASS OF DRUG 
Anticoagulant. 
MECHANISM OF ACTION 
Heparin is a naturally occurring mucopolysaccharide with  _in vitro_ and _in vivo_ anticoagulant 
activity. 
Heparin inhibits reactions that lead to the clotting of blood and the formation of fibrin clots 
both  _in  vitro_  and  _in  vivo_.    Heparin  acts  at  multiple  sites  in  the  normal  coagulation  system.
 
Small amounts of heparin in combination with antithrombin III (heparin cofactor) can inhibit 
thrombosis  by inactivating activated Factor  X and inhibiting the conversion of prothrombin 
to  thrombin.    Once  active  thrombosis  has  developed,  larger  
                                
                                Lue koko asiakirja
                                
                            

Samankaltaiset tuotteet

Etsi tähän tuotteeseen liittyviä ilmoituksia

Näytä asiakirjojen historia